Reverted Products definition

Reverted Products shall have the meaning described in Section 15.2(a).
Reverted Products has the meaning set forth in Section 11.5(d).
Reverted Products means those Licensed Products as to which Cubist or Chiron exercise termination rights pursuant to this Article 13 (and could mean, in any particular context, all of the Licensed Products if this Agreement is terminated in its entirety), and the termReverted Country” shall mean any country within the Territory as to which Cubist or Chiron exercise termination rights pursuant to this Article 13 (and could mean, in any particular context, all of the countries within the Territory if this Agreement were terminated in its entirety or, with respect to any particular Licensed Product, if Chiron’s rights to such Licensed Product are terminated as to all countries within the Territory).

Examples of Reverted Products in a sentence

  • Oragenics shall promptly assign to Intrexon, and will provide full copies of, all regulatory approvals and regulatory filings that relate specifically and solely to Reverted Products.

  • At Intrexon’s request, ZIOPHARM shall promptly provide to Intrexon copies of all agreements between ZIOPHARM or its Affiliates and Third Party suppliers, vendors, or distributors that relate to the supply, sale, or distribution of Reverted Products in the Territory.

  • ZIOPHARM shall promptly assign to Intrexon, and will provide full copies of, all regulatory approvals and regulatory filings that relate specifically and solely to Reverted Products.

  • At Intrexon’s request, Oragenics shall promptly provide to Intrexon copies of all agreements between Oragenics or its Affiliates and Third Party suppliers, vendors, or distributors that relate to the supply, sale, or distribution of Reverted Products in the Territory.

  • To the extent that there exist any regulatory approvals and regulatory filings that relate both to Reverted Products and other products, ZIOPHARM shall provide copies of the portions of such regulatory filings that relate to Reverted Products and shall reasonably cooperate to assist Intrexon in obtaining the benefits of such regulatory approvals with respect to the Reverted Products.

  • At Intrexon’s request, ZIOPHARM shall promptly: (x) with respect to such Third Party agreements relating solely to the applicable Reverted Products, immediately assign (or cause to be assigned), such agreements to Intrexon, and (y) with respect to all other such Third Party agreements, ZIOPHARM shall reasonably cooperate to assist Intrexon in obtaining the benefits of such agreements.

  • Oragenics shall transfer to Intrexon all such quantities of Reverted Products without charge, except that Intrexon shall pay the reasonable costs of shipping.

  • Intrexon shall have the right to develop and commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to ZIOPHARM, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • At Intrexon’s request, Oragenics shall promptly: (A) with respect to such Third Party agreements relating solely to the applicable Reverted Products and permitting assignment, immediately assign (or cause to be assigned), such agreements to Intrexon, and (B) with respect to all other such Third Party agreements, Oragenics shall reasonably cooperate to assist Intrexon in obtaining the benefits of such agreements.

  • ZIOPHARM shall transfer to Intrexon all such quantities of Reverted Products without charge, except that Intrexon shall pay the reasonable costs of shipping.


More Definitions of Reverted Products

Reverted Products. Distributing Party" and "Other Party" are terms defined in the Distribution Agreement). Notwithstanding the foregoing, the parties agree that the distribution of any Product shall be in Collagen's sole discretion and shall be outside the scope of the Distribution Agreement if the collaborative development of such Product is terminated by Innovasive and such Product is subsequently completed and commercialized by Collagen pursuant to this Section 10.2(ii). [*] Application for an order granting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 has been made. Confidential portions of this document have been redacted and marked with an [*] and have been filed with the Securities and Exchange Commission separately with such application.
Reverted Products means: (a) all Therapeutic Products for a Selected Disease for which deCODE terminates this Agreement pursuant to Section 14.6(a)(i) prior to the first Registration in any Major Country of a Therapeutic Product for such Selected Disease; (b) all Therapeutic Products in a given Major Country for a Selected Disease for which deCODE terminates this Agreement in the Major Country pursuant to Section 14.6(a)(ii) after the first Registration in any Major Country of a Therapeutic Product for such Selected Disease; (c) all Diagnostic Products for a Selected Disease for which deCODE terminates this Agreement pursuant to Section 14.6(b)(i) prior to the first Registration in any Major Country of a Diagnostic Product for such Selected Disease; (d) all Diagnostic Products in a given Major Country for a Selected Disease for which deCODE terminates this Agreement in the Major Country pursuant to Section 14.6(b)(ii) after the first Registration in any Major Country of a Diagnostic Product for such Selected Disease; (e) a given Roche Product in a given country for which deCODE terminates this Agreement pursuant to Section 14.7 after Registration in such country of such Roche Product; (f) all Therapeutic Products for a Selected Disease for which a Validated Target was obtained as of the effective date of termination of this Agreement by deCODE pursuant to Section 14.5(a)(iii)(2); and (g) all Diagnostic Products for diagnosing a Disease that was a Selected Disease as of the effective date of termination of this Agreement by deCODE pursuant to Section 14.5(a)(iii)(2). Notwithstanding the foregoing, a Reverted Product shall not include a Roche Product which comprises a Roche Compound that, at the effective date of such termination, is being marketed, prepared for commercial launch or in clinical development or for which Roche, its Affiliate or sublicensee can document a substantial plan to clinically develop (provided that such Roche Compound is a Clinical Candidate), for an indication in a Selected Disease if Roche, its Affiliate or sublicensee, at the effective date of such termination, is then marketing, preparing for commercial launch, clinically developing, or can document a substantial plan for clinically developing a given product for the same indication; provided, that such given product, at the Effective Date, was not being marketed in any country by Roche, an Affiliate or sublicensee.
Reverted Products shall have the meaning set forth in Section 8.4.2. 1. 107 “***” means any ***.
Reverted Products shall have the meaning given such term in Section 8.2.
Reverted Products is defined in Section 17.8(b)(i) (Additional Effects of Certain Termination).